Search
for
Sort by
Research 30 of 1000+
- Dysregulation of Leukaemia Inhibitory Factor (LIF) Signalling Pathway by Supraphysiological Dose of Testosterone in Female Sprague Dawley Rats During Development of Endometrial Receptivity
- The effect of inflammatory cytokines on the risk of hypertrophic scar: A Mendelian Randomization Study
- Efficient establishment of an optimized culture condition for cashmere goat primary hair follicle stem cells
- Hair graying and loss induced by imatinib mesylate
- Follikelhormone
- Single Best Answers
- Section 2: Single Best Answers Questions 51–120
- A Case of Inflammatory Nonscarring Alopecia Associated With the Tyrosine Kinase Inhibitor Nilotinib
- Dasatinib-Induced Leukotrichia in a Patient With Chronic Myelogenous Leukemia
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection
- Roles of tumor suppressors in regulating tumor-associated inflammation
- Sorafenib-induced Facial Acneiform Eruption
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Cytostatics and immunosuppressive drugs
- Hair Re-Pigmentation After Nilotinib
- Cutaneous drug reactions
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- Factors regulating quiescent stem cells: insights from the intestine and other self-renewing tissues
- Angiogenesis: a Dynamic Balance of Stimulators and Inhibitors
- Bone Morphogenetic Protein Antagonist Noggin Promotes Skin Tumorigenesis via Stimulation of the Wnt and Shh Signaling Pathways
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Clinical Snippets
- FGF Family: From Drug Development to Clinical Application
- Poster Presentations
- Nilotinib-induced generalized keratosis pilaris: Report of a rare case